CLINICAL TRIALS PROFILE FOR SELENOMETHIONINE SE-75
✉ Email this page to a colleague
All Clinical Trials for selenomethionine se-75
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00112892 ↗ | Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors | Completed | Roswell Park Cancer Institute | Phase 1 | 2004-08-01 | RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Selenium may allow higher doses of irinotecan to be given. Giving irinotecan together with selenium may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of selenium when given together with irinotecan in treating patients with advanced solid tumors. |
| NCT00212186 ↗ | Selenium Supplementation of Patients With Cirrhosis | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A | 1998-10-01 | The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium. |
| NCT00212186 ↗ | Selenium Supplementation of Patients With Cirrhosis | Completed | Vanderbilt University | N/A | 1998-10-01 | The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium. |
| NCT00212186 ↗ | Selenium Supplementation of Patients With Cirrhosis | Completed | Vanderbilt University Medical Center | N/A | 1998-10-01 | The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium. |
| NCT00217516 ↗ | Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer | Completed | National Cancer Institute (NCI) | Phase 1 | 2005-03-01 | RATIONALE: The use of nutritional supplements, such as selenium, may stop prostate cancer from growing. Internal radiation, such as brachytherapy, uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving selenium before brachytherapy may be an effective treatment for prostate cancer. PURPOSE: This randomized phase I trial is studying selenium to see how well it works compared to placebo in treating patients who are undergoing brachytherapy for stage I or stage II prostate cancer. |
| NCT00217516 ↗ | Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer | Completed | Roswell Park Cancer Institute | Phase 1 | 2005-03-01 | RATIONALE: The use of nutritional supplements, such as selenium, may stop prostate cancer from growing. Internal radiation, such as brachytherapy, uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving selenium before brachytherapy may be an effective treatment for prostate cancer. PURPOSE: This randomized phase I trial is studying selenium to see how well it works compared to placebo in treating patients who are undergoing brachytherapy for stage I or stage II prostate cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for selenomethionine se-75
Condition Name
| Condition Name for selenomethionine se-75 | |
| Intervention | Trials |
| Prostate Cancer | 2 |
| Chemotherapeutic Agent Toxicity | 1 |
| Stage III Squamous Cell Carcinoma of the Hypopharynx | 1 |
| Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for selenomethionine se-75
Trials by Country
Clinical Trial Progress for selenomethionine se-75
Clinical Trial Phase
Clinical Trial Sponsors for selenomethionine se-75
Sponsor Name
